Review Article Role of "oncogenic nexus" of CIP2A in breast oncogenesis: how does it work?

Valeriy V. Lyzogubov, Ruslana Tytarenko, Vasiliy S. Usenko, Ivan T. Gout, Sergey K. Azatjan, Valeriy V. Filonenko, Yuriy A. Gaydar, Lilya O. Savinska, Immunohistochemical analysis of S6K1 and S6K2 localization in human breast tumors. Experimental Oncology. ,vol. 26, pp. 294- ,(2004)

Pradip De, Nandini Dey, Brian Leyland-Jones, MYC-xing it up with PIK3CA mutation and resistance to PI3K inhibitors: summit of two giants in breast cancers. American Journal of Cancer Research. ,vol. 5, pp. 1- 19 ,(2015)

Olle Stål, Gizeh Pérez-Tenorio, Linda Åkerberg, Birgit Olsson, Bo Nordenskjöld, Lambert Skoog, Lars Erik Rutqvist, Akt kinases in breast cancer and the results of adjuvant therapy Breast Cancer Research. ,vol. 5, pp. 1- 8 ,(2003) , 10.1186/BCR569

Sami Ventelä, Eleonora Sittig, Leni Mannermaa, Juho-Antti Mäkelä, Jarmo Kulmala, Eliisa Löyttyniemi, Leena Strauss, Olli Cárpen, Jorma Toppari, Reidar Grénman, Jukka Westermarck, CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance. Oncotarget. ,vol. 6, pp. 144- 158 ,(2015) , 10.18632/ONCOTARGET.2670

Ion Cristóbal, Paula González-Alonso, Lina Daoud, Esther Solano, Blanca Torrejón, Rebeca Manso, Juan Madoz-Gúrpide, Federico Rojo, Jesús García-Foncillas, Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer Marine Drugs. ,vol. 13, pp. 3276- 3286 ,(2015) , 10.3390/MD13063276

Anchit Khanna, John E. Pimanda, Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers International Journal of Cancer. ,vol. 138, pp. 525- 532 ,(2016) , 10.1002/IJC.29431

Pradip De, Jennifer Carlson, Brian Leyland-Jones, Nandini Dey, Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands. Oncotarget. ,vol. 5, pp. 4581- 4602 ,(2014) , 10.18632/ONCOTARGET.2127

Clemens A. Schmitt, Senescence, apoptosis and therapy — cutting the lifelines of cancer Nature Reviews Cancer. ,vol. 3, pp. 286- 295 ,(2003) , 10.1038/NRC1044

Jukka Westermarck, William C. Hahn, Multiple pathways regulated by the tumor suppressor PP2A in transformation Trends in Molecular Medicine. ,vol. 14, pp. 152- 160 ,(2008) , 10.1016/J.MOLMED.2008.02.001

Trond Lamark, Terje Johansen, Autophagy: links with the proteasome Current Opinion in Cell Biology. ,vol. 22, pp. 192- 198 ,(2010) , 10.1016/J.CEB.2009.11.002